Log in to save to my catalogue

Efficacy, Convenience, Safety and Durability of DTG-Based Antiretroviral Therapies: Evidence from a...

Efficacy, Convenience, Safety and Durability of DTG-Based Antiretroviral Therapies: Evidence from a...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_62bc6563a8c44110bcb95633ee168caf

Efficacy, Convenience, Safety and Durability of DTG-Based Antiretroviral Therapies: Evidence from a Prospective Study by the Italian MaSTER Cohort

About this item

Full title

Efficacy, Convenience, Safety and Durability of DTG-Based Antiretroviral Therapies: Evidence from a Prospective Study by the Italian MaSTER Cohort

Publisher

Switzerland: MDPI AG

Journal title

Viruses, 2023-04, Vol.15 (4), p.924

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Background: Dolutegravir (DTG) is recommended by international guidelines as a main component of an optimal initial regimen of cART (combination antiretroviral treatment) in people living with HIV (PLWH) and in case of switching for failure or optimization strategies. However, studies on the performance of DTG-containing regimens and indications fo...

Alternative Titles

Full title

Efficacy, Convenience, Safety and Durability of DTG-Based Antiretroviral Therapies: Evidence from a Prospective Study by the Italian MaSTER Cohort

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_62bc6563a8c44110bcb95633ee168caf

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_62bc6563a8c44110bcb95633ee168caf

Other Identifiers

ISSN

1999-4915

E-ISSN

1999-4915

DOI

10.3390/v15040924

How to access this item